Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment.

[1]  M. A. Marx,et al.  Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrations. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  R. Leclercq,et al.  Resistance to glycopeptides in enterococci. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Piraino,et al.  Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  M. Gilchrist,et al.  Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.